硝子体手術器具の世界市場：洞察、競合情勢、市場予測：2028年

世界の硝子体手術器具の市場規模は2022年に11億2,000万米ドルと評価され、2023年から2028年までの予測期間中に7.12%のCAGRで拡大すると予測されています。硝子体手術器具の需要は、主に網膜剥離、糖尿病性網膜症などの網膜疾患の有病率の増加によって後押しされています。さらに、眼科領域における技術の進歩や新製品の発売の増加は、市場のプラス成長に影響を与える他の主要な要因です。さらに、網膜裂孔および網膜剥離に関連する外傷症例の増加も、2023年～2028年の予測期間中、硝子体手術器具市場の全体的な成長に寄与するとみられています。

IABPの一部であるVision Loss Expert Group 2020が提供したデータによると、2020年には約100万人が糖尿病性網膜症による失明を患い、約300万人が中等度から重度の視力障害を患っていると推定されています。このように、様々な網膜疾患の有病率の増加は、最終的に硝子体手術器具の市場を押し上げると予測されます。

さらに、国際糖尿病連合（IDF）2019が提供したデータでは、糖尿病に罹患する人の総数は、世界全体で2030年の5億7,800万人から2045年には7億人に増加すると推定されています。したがって、糖尿病の有病率の増加も糖尿病性網膜症の症例の増加に寄与する重要な要因であり、これも予測期間中に硝子体手術器具市場を牽引することになります。

硝子体手術器具市場のもう一つの主な促進要因は、技術進歩製品の採用や新製品の発売の増加です。例えば、2021年1月、D.O.R.C Dutch Ophthalmic Research Center（International）B.V.は、カナダ保健省からTissueBlueTMの承認を受けました。この製品は、硝子体手術中の内境界膜（ILM）の染色に使用されます。したがって、製品の発売や承認の増加、眼科領域における技術進歩の増加が、硝子体手術器具市場の成長を後押ししています。

しかし、硝子体手術に関連する合併症と硝子体手術器具に関連する高コストは、硝子体手術器具市場の成長を制限する可能性がある市場の障壁の一部です。

当レポートでは、世界の硝子体手術器具市場について調査し、市場の概要とともに、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 硝子体手術器具市場レポートのイントロダクション

第2章 硝子体手術器具市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 硝子体手術器具市場の主要な要因分析

• 硝子体手術器具市場の促進要因
• 硝子体手術器具市場の抑制要因と課題
• 硝子体手術器具市場の機会

第5章 硝子体手術器具市場におけるポーターのファイブフォース分析

第6章 硝子体手術器具市場の概要

• 製品別
• 用途別
• エンドユーザー別
• 地域別

第7章 硝子体手術器具市場における企業と製品プロファイル

• Alcon
• Carl Zeiss Meditec AG
• Leica Microsystems
• IRIDEX Corporation
• Lumenis Be Ltd.
• NIDEK CO., LTD.
• D.O.R.C Dutch Ophthalmic Research Center (International) B.V
• Geuder AG
• Optos
• Hoya Surgical Optics
• BVI
• Johnson & Johnson, Inc.

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Vitrectomy Devices Market in Global (2020-2028)
• Table 3: Vitrectomy Devices Market in Global by Product (2020-2028)
• Table 4: Vitrectomy Devices Market in Global by Application (2020-2028)
• Table 5: Vitrectomy Devices Market in Global by End-users (2020-2028)
• Table 6: Vitrectomy Devices Market in Global by Geography (2020-2028)
• Table 7: Vitrectomy Devices Market in North America (2020-2028)
• Table 8: Vitrectomy Devices Market in North America by Country (2020-2028)
• Table 9: Vitrectomy Devices Market in the United States (2020-2028)
• Table 10: Vitrectomy Devices Market in Canada (2020-2028)
• Table 11: Vitrectomy Devices Market in Mexico (2020-2028)
• Table 12: Vitrectomy Devices Market in Europe (2020-2028)
• Table 13: Vitrectomy Devices Market in Europe by Country (2020-2028)
• Table 14: Vitrectomy Devices Market in France (2020-2028)
• Table 15: Vitrectomy Devices Market in Germany (2020-2028)
• Table 16: Vitrectomy Devices Market in the United Kingdom (2020-2028)
• Table 17: Vitrectomy Devices Market in Italy (2020-2028)
• Table 18: Vitrectomy Devices Market in Spain (2020-2028)
• Table 19: Vitrectomy Devices Market in the Rest of Europe (2020-2028)
• Table 20: Vitrectomy Devices Market in Asia-Pacific (2020-2028)
• Table 21: Vitrectomy Devices Market in Asia-Pacific by Country (2020-2028)
• Table 22: Vitrectomy Devices Market in China (2020-2028)
• Table 23: Vitrectomy Devices Market in Japan (2020-2028)
• Table 24: Vitrectomy Devices Market in India (2020-2028)
• Table 25: Vitrectomy Devices Market in Australia (2020-2028)
• Table 26: Vitrectomy Devices Market in South Korea (2020-2028)
• Table 27: Vitrectomy Devices Market in Rest of Asia-Pacific (2020-2028)
• Table 28: Vitrectomy Devices Market in the Rest of the World (2020-2028)
• Table 29: Vitrectomy Devices Market in RoW by Region (2020-2028)
• Table 30: Vitrectomy Devices Market in the Middle East (2020-2028)
• Table 31: Vitrectomy Devices Market in Africa (2020-2028)
• Table 32: Vitrectomy Devices Market in South America (2020-2028)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Vitrectomy Devices Market in Global (2020-2028)
• Figure 3: Vitrectomy Devices Market in Global by Product (2020-2028)
• Figure 4: Vitrectomy Devices Market in Global by Application (2020-2028)
• Figure 5: Vitrectomy Devices Market in Global by End-user (2020-2028)
• Figure 6: Vitrectomy Devices Market in Global by Geography (2020-2028)
• Figure 7: Vitrectomy Devices Market in North America (2020-2028)
• Figure 8: Vitrectomy Devices Market in North America by Country (2020-2028)
• Figure 9: Vitrectomy Devices Market in the United States (2020-2028)
• Figure 10: Vitrectomy Devices Market in Canada (2020-2028)
• Figure 11: Vitrectomy Devices Market in Mexico (2020-2028)
• Figure 12: Vitrectomy Devices Market in Europe (2020-2028)
• Figure 13: Vitrectomy Devices Market in Europe by Country (2020-2028)
• Figure 14: Vitrectomy Devices Market in France (2020-2028)
• Figure 15: Vitrectomy Devices Market in Germany (2020-2028)
• Figure 16: Vitrectomy Devices Market in the United Kingdom (2020-2028)
• Figure 17: Vitrectomy Devices Market in Italy (2020-2028)
• Figure 18: Vitrectomy Devices Market in Spain (2020-2028)
• Figure 19: Vitrectomy Devices Market in the Rest of Europe (2020-2028)
• Figure 20: Vitrectomy Devices Market in Asia-Pacific (2020-2028)
• Figure 21: Vitrectomy Devices Market in Asia-Pacific by Country (2020-2028)
• Figure 22: Vitrectomy Devices Market in China (2020-2028)
• Figure 23: Vitrectomy Devices Market in Japan (2020-2028)
• Figure 24: Vitrectomy Devices Market in India (2020-2028)
• Figure 25: Vitrectomy Devices Market in Australia (2020-2028)
• Figure 26: Vitrectomy Devices Market in South Korea (2020-2028)
• Figure 27: Vitrectomy Devices Market in Rest of Asia-Pacific (2020-2028)
• Figure 28: Vitrectomy Devices Market in the Rest of the World (2020-2028)
• Figure 29: Vitrectomy Devices Market in RoW by Region (2020-2028)
• Figure 30: Vitrectomy Devices Market in the Middle East (2020-2028)
• Figure 31: Vitrectomy Devices Market in Africa (2020-2028)
• Figure 32: Vitrectomy Devices Market in South America (2020-2028)
• Figure 33: Market Drivers
• Figure 34: Market Barriers
• Figure 35: Marker Opportunities
• Figure 36: PORTER'S Five Force Analysis

Vitrectomy Devices Market By Product (Vitrectomy Systems And Vitrectomy Accessories), Application (Diabetic Retinopathy, Retinal Detachment, Vitreous Hemorrhage, And Others), End-User (Hospitals, Ophthalmology Clinics, And Ambulatory Surgical Centers), and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of retinal disorders such as diabetic retinopathy and increase in new product launches and technical advancements in the domain of ophthalmology.

The global Vitrectomy Devices market was valued at USD 1.12 billion in 2022, growing at a CAGR of 7.12% during the forecast period from 2023 to 2028. The demand for Vitrectomy Devices is primarily being boosted by the increasing prevalence of retinal disorders such as retinal detachment, diabetic retinopathy, and others. Additionally, the increase in technological advancements and new product launches in the domain of ophthalmology are other key factors influencing the positive growth of the market. Further, the increasing number of trauma cases associated with retinal tear and detachment is also contributing to the overall growth of the Vitrectomy Devices market during the forecast period from 2023-2028.

Vitrectomy Devices Market Dynamics:

According to the data provided by Vision Loss Expert Group 2020, which is a part of IABP estimated that around 1 million people were suffering from blindness due to Diabetic Retinopathy in the year 2020, and around 3 million people had moderate to severe vision impairment, globally. Thus, the rising prevalence of various retinal disorders will eventually boost the market for Vitrectomy Devices.

Additionally, the data provided by the International Diabetes Federation (IDF) 2019, it was estimated that the total number of people suffering from diabetes will increase from 578 million in 2030 to 700 million in 2045, globally. Thus, the increasing prevalence of diabetes is also a significant factor contributing to the rise in the cases of diabetic retinopathy, which will also drive the Vitrectomy devices market during the forecast period.

Another key driver for the Vitrectomy devices market is the increase in the adoption of technological advancements products and new product launches. For Instance, in January 2021, D.O.R.C Dutch Ophthalmic Research Center (International) B.V. received approval of TissueBlueTM, from Health Canada. The product is used for staining of the internal limiting membrane (ILM), during vitrectomy surgeries. Therefore, the rising product launches, approvals, and increase in technological advancements in the domain of ophthalmology are propelling the growth of the vitrectomy devices market.

However, the complications associated with Vitrectomy procedures and the high cost associated with Vitrectomy Devices are some of the market barriers that may restrict the growth of the Vitrectomy Devices market.

Vitrectomy Devices Market Segment Analysis:

Vitrectomy Devices Market by Product (Vitrectomy Systems and Vitrectomy Accessories), Application (Diabetic Retinopathy, Retinal Detachment, Vitreous Hemorrhage, and Others), End-users (Hospitals, Ophthalmology Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the Vitrectomy Devices market, the Vitrectomy Systems category is expected to amass a significant revenue share in the year 2022. This can be attributed to the various advantages provided by the vitrectomy systems such as the presence of smart vitrectomy systems. Smart vitrectomy systems consisting of artificial intelligence, helps in providing real-time assistance to surgeons during the surgery in decision-making and provides more personalized and effective interventions. Additionally, continuous advancements in fluidic control systems and illumination technologies in vitrectomy devices are further contributing to better surgical environments. These systems ensure stable vitrectomy procedures, while improved illumination of the vitrectomy systems facilitates clearer visualization during the surgical procedure. Thus, the advantages provided by the Vitrectomy Systems are some of the key factors contributing to the growth of the segment.

Furthermore, as the demand for this segment grows, various products are launched in the market. For Instance, in March 2022, D.O.R.C Dutch Ophthalmic Research Center (International) B.V launched EVA NEXUS, an integrated system consisting of retina, cataract, and combined surgery capabilities.

Therefore, owing to the above-mentioned advantages and applications provided by Vitrectomy Systems, and the new product launches in this category is expected to register significant growth, thereby driving the growth of the overall Vitrectomy Devices market during the forecast period.

North America is expected to dominate the overall Vitrectomy Devices Market:

Among all the regions, North America is estimated to account for the largest share of the Vitrectomy Devices market in the year 2022. This can be attributed to the presence of a large patient pool suffering from various ophthalmological disorders. Additionally, easy availability of technologically advanced products, high awareness of diabetic retinopathy, easy availability of skilled ophthalmologists, and presence of major market players are among key factors influencing the growth of the market in North America.

According to a study published in JAMA Ophthalmology in the year 2021, "Prevalence of Diabetic Retinopathy in the US", it was estimated that 9.6 million people in the United States suffered from diabetic retinopathy in 2021. According to the same source, around 1.84 million people in the United States have vision threatening diabetic retinopathy (VTDR). Thus, the rising prevalence of various ophthalmological disorders will boost the market for Vitrectomy Devices in the United States, which in return will boost the overall Vitrectomy devices in North America.

According to the data provided by the Centers for Disease Control and Prevention (CDC) 2023, it was estimated that 29.7 million people, which accounts for 8.9% of the total population in the United States were diagnosed with Diabetes in the year 2021. Thus, the increasing prevalence of diabetes is a significant factor, which is contributing to the rise in the cases of diabetic retinopathy, which will eventually boost the market for Vitrectomy devices in the region.

Further, the presence of key market players and various key product launches and approvals in the region are some of the other factors that are influencing the positive growth of the market in the region. For Example, in April 2022, Carl Zeiss Meditec AG received FDA approval for the QUATERA 700 system.

Therefore, the factors mentioned above, and the presence of key market leaders with increasing product launches and product approvals in the region are some of the important factors which are thereby responsible for driving the overall market for Vitrectomy Devices in North America during the forecast period.

Vitrectomy Devices Market Key Players:

Some of the key market players operating in the Vitrectomy Devices market include: Alcon, Carl Zeiss Meditec AG, Lecia Microsystems, IRIDEX Corporation, Lumines Be Ltd., NIDEK CO., LTD., D.O.R.C Dutch Ophthalmic Research Center (International) B.V., Geuder AG, Optos, Hoya Surgical Optics, BVI, and Johnson & Johnson, Inc.

Recent Developmental Activities in the Vitrectomy Devices Market:

• In July 2021, D.O.R.C Dutch Ophthalmic Research Center (International) B.V. launched its EVA EquiPhaco angled needles, equipped with enhanced chamber stability and ultrasonic efficiency.
• In January 2019, Hoya Surgical Optics acquired Mid Labs and Fritz Ruck. The main objective of the acquisition is to help Hoya Surgical Optics to expand its product offerings.

Key Takeaways from the Vitrectomy Devices Market Report Study:

• Market size analysis for current Vitrectomy Devices market size (2022), and market forecast for 5 years (2023-2028)
• Top key product/and technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Vitrectomy Devices market.
• Various opportunities available for the other competitors in the Vitrectomy Devices market space.
• What are the top-performing segments in 2022? How these segments will perform in 2028?
• Which are the top-performing regions and countries in the current Vitrectomy Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Vitrectomy Devices market growth in the coming future?

Target Audience who can be benefited from this Vitrectomy Devices Market Report Study:

• Vitrectomy Devices product providers
• Research organizations and consulting companies
• Vitrectomy Devices -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Vitrectomy Devices
• Various End-users who want to know more about the Vitrectomy Devices market and the latest technological developments in the Vitrectomy Devices market

Frequently Asked Questions for the Vitrectomy Devices Market:

1. What is meant by Vitrectomy Devices?

• Vitrectomy Devices are surgical instruments used during vitrectomy. Vitrectomy refers to a surgical technique to remove or replace the vitreous humor (gel-like substance) present inside the eye. These devices typically include vitrectomy systems and other accessories that aid in the removal of vitreous tissue.

2. What is the market for global Vitrectomy Devices?

• The global Vitrectomy Devices market was valued at USD 1.12 billion in 2022, growing at a CAGR of 7.12% during the forecast period from 2023 to 2028.

3. What are the drivers for the global Vitrectomy Devices market?

• The Vitrectomy Devices market is slated to witness prosperity owing to factors such as the increasing prevalence of retinal disorders such as Diabetic Retinopathy and other factors causing the disease. Additionally, new product launches and technical advancements in the domain of ophthalmology will further propel the growth of the market. Further, an increase in several trauma cases associated with retinal tear and detachment will also result in appreciable revenue growth in the Vitrectomy Devices market during the forecast period (2023-2028).

4. Who are the key players operating in the global Vitrectomy Devices market?

• Some of the key market players operating in the Vitrectomy Devices market include Alcon, Carl Zeiss Meditec AG, Lecia Microsystems, IRIDEX Corporation, Lumines Be Ltd., NIDEK CO., LTD., D.O.R.C Dutch Ophthalmic Research Center (International) B.V, Geuder AG, Optos, Hoya Surgical Optics, BVI, and Johnson & Johnson, Inc.

5. Which region has the highest share in the global Vitrectomy Devices market?

• North America is expected to dominate the overall Vitrectomy Devices Market during the forecast period, 2023 to 2028. Due to the presence of a large patient pool suffering from ophthalmological disorders. Additionally, the easy availability of technologically advanced products in the region is another contributing factor to the growth of the Vitrectomy Devices market in North America. Further, the region has a very potent market for product development and launches, and the presence of a high concentration of market players in the region will also help in boosting the market for vitrectomy devices in North America.

Table of Contents

1. Vitrectomy Devices Market Report Introduction

2. Vitrectomy Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Vitrectomy Devices Market Key Factors Analysis

• 4.1. Vitrectomy Devices Market Drivers
  • 4.1.1. Increasing prevalence of Retinal Disorders such as Diabetic Retinopathy and other factors causing the disease
  • 4.1.2. New product launches and technical advancements in the domain of ophthalmology
  • 4.1.3. Increase in the number of Trauma cases associated with retinal tear and detachment
• 4.2. Vitrectomy Devices Market Restraints and Challenges
  • 4.2.1. Complications associated with Vitrectomy
  • 4.2.2. High cost associated with Vitrectomy Devices
• 4.3. Vitrectomy Devices Market Opportunities
  • 4.3.1. Potential growth opportunities in the emerging markets

5. Vitrectomy Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Vitrectomy Devices Market Layout

• 6.1. By Product
  • 6.1.1. Vitrectomy Systems
  • 6.1.2. Vitrectomy Accessories
• 6.2. By Application
  • 6.2.1. Diabetic Retinopathy
  • 6.2.2. Retinal Detachment
  • 6.2.3. Vitreous Hemorrhage
  • 6.2.4. Other Applications
• 6.3. By End-user
  • 6.3.1. Hospitals
  • 6.3.2. Ophthalmology Clinics
  • 6.3.3. Ambulatory Surgical Centers
• 6.4. By Geography
  • 6.4.1. North America
    • 6.4.1.1. United States Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.1.2. Canada Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.1.3. Mexico Vitrectomy Devices Market Size in USD million (2020-2028)
  • 6.4.2. Europe
    • 6.4.2.1. France Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.2.2. Germany Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.2.3. United Kingdom Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.2.4. Italy Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.2.5. Spain Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.2.6. Rest of Europe Vitrectomy Devices Market Size in USD million (2020-2028)
  • 6.4.3. Asia-Pacific
    • 6.4.3.1. China Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.3.2. Japan Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.3.3. India Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.3.4. Australia Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.3.5. South Korea Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.3.6. Rest of Asia-Pacific Vitrectomy Devices Market Size in USD million (2020-2028)
  • 6.4.4. Rest of the World (RoW)
    • 6.4.4.1. Middle East Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.4.2. Africa Vitrectomy Devices Market Size in USD million (2020-2028)
    • 6.4.4.3. South America Vitrectomy Devices Market Size in USD million (2020-2028)

7. Vitrectomy Devices Market Company and Product Profiles

• 7.1. Alcon
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Carl Zeiss Meditec AG
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Leica Microsystems
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. IRIDEX Corporation
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Lumenis Be Ltd.
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. NIDEK CO., LTD.
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. D.O.R.C Dutch Ophthalmic Research Center (International) B.V
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Geuder AG
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Optos
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Hoya Surgical Optics
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. BVI
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Johnson & Johnson, Inc.
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us